Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 3
2015 2
2016 4
2017 2
2018 2
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.
Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, Petrachenkova M, Lehr T, Lempp FA, Wedemeyer H, Haag M, Schwab M, Haefeli WE, Blank A, Urban S. Bogomolov P, et al. Among authors: lempp fa. J Hepatol. 2016 Sep;65(3):490-8. doi: 10.1016/j.jhep.2016.04.016. Epub 2016 Apr 27. J Hepatol. 2016. PMID: 27132170 Clinical Trial.
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
Tortorici MA, Beltramello M, Lempp FA, Pinto D, Dang HV, Rosen LE, McCallum M, Bowen J, Minola A, Jaconi S, Zatta F, De Marco A, Guarino B, Bianchi S, Lauron EJ, Tucker H, Zhou J, Peter A, Havenar-Daughton C, Wojcechowskyj JA, Case JB, Chen RE, Kaiser H, Montiel-Ruiz M, Meury M, Czudnochowski N, Spreafico R, Dillen J, Ng C, Sprugasci N, Culap K, Benigni F, Abdelnabi R, Foo SC, Schmid MA, Cameroni E, Riva A, Gabrieli A, Galli M, Pizzuto MS, Neyts J, Diamond MS, Virgin HW, Snell G, Corti D, Fink K, Veesler D. Tortorici MA, et al. Among authors: lempp fa. Science. 2020 Nov 20;370(6519):950-957. doi: 10.1126/science.abe3354. Epub 2020 Sep 24. Science. 2020. PMID: 32972994
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S. Ni Y, et al. Among authors: lempp fa. Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19. Gastroenterology. 2014. PMID: 24361467
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P, Metz P, Lempp FA, Bender S, Qu B, Schöneweis K, Seitz S, Tu T, Restuccia A, Frankish J, Dächert C, Schusser B, Koschny R, Polychronidis G, Schemmer P, Hoffmann K, Baumert TF, Binder M, Urban S, Bartenschlager R. Mutz P, et al. Among authors: lempp fa. Gastroenterology. 2018 May;154(6):1791-1804.e22. doi: 10.1053/j.gastro.2018.01.044. Epub 2018 Feb 1. Gastroenterology. 2018. PMID: 29410097 Free article.
Inhibitors of hepatitis B virus attachment and entry.
Lempp FA, Urban S. Lempp FA, et al. Intervirology. 2014;57(3-4):151-7. doi: 10.1159/000360948. Epub 2014 Jul 15. Intervirology. 2014. PMID: 25034482 Free article. Review.
Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation.
Lempp FA, Schlund F, Rieble L, Nussbaum L, Link C, Zhang Z, Ni Y, Urban S. Lempp FA, et al. Nat Commun. 2019 May 22;10(1):2265. doi: 10.1038/s41467-019-10211-2. Nat Commun. 2019. PMID: 31118422 Free PMC article.
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.
Lempp FA, Urban S. Lempp FA, et al. Viruses. 2017 Jul 4;9(7):172. doi: 10.3390/v9070172. Viruses. 2017. PMID: 28677645 Free PMC article. Review.
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.
Lempp FA, Ni Y, Urban S. Lempp FA, et al. Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):580-9. doi: 10.1038/nrgastro.2016.126. Epub 2016 Aug 18. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27534692 Review.
T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B, Ni Y, Lempp FA, Vondran FWR, Urban S. Qu B, et al. Among authors: lempp fa. J Virol. 2018 Nov 12;92(23):e01117-18. doi: 10.1128/JVI.01117-18. Print 2018 Dec 1. J Virol. 2018. PMID: 30232183 Free PMC article.
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S. Nkongolo S, et al. Among authors: lempp fa. J Hepatol. 2014 Apr;60(4):723-31. doi: 10.1016/j.jhep.2013.11.022. Epub 2013 Dec 1. J Hepatol. 2014. PMID: 24295872
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback